Peptide dosing reference
Every compound in the Dosify Me app, as a plain-English card: how to reconstitute each vial size, what a dose reads on the syringe, how often it is taken, what users report, side effects, and the sources behind it. 42 compounds.
Informational use only. Nothing here is medical advice; talk to a licensed healthcare provider before starting or changing any protocol.
How to read these pages
Each compound page is built from the same Dosify Me compound database that powers the app and the calculators. It shows the vial sizes, the standard bacteriostatic water for each one, the concentration that gives, and what a listed amount reads on an insulin syringe. It also gathers the side effects, medication cautions and cited sources for the compound.
The pages are grouped by the categories the app uses, and a compound appears in every group its sources support. The sentence after each name is the reason it is filed there. Amounts on these pages are listed for reference only: Dosify Me does not tell you what dose to take.
Anti-Aging & Skin
- AHK-Cu — Studied for skin repair, collagen support, and anti-aging effects in cosmetic formulations.
- GHK-Cu — Boosts collagen production and skin repair as documented topically.
- GLOW — Includes GHK-Cu, well-studied for skin collagen and repair.
- KLOW — Includes GHK-Cu, studied for skin collagen production and repair.
- Melanotan I — Stimulates melanin for skin tanning and protection, approved for light-sensitivity.
- Melanotan II — Stimulates melanin for deeper tan, studied for skin effects.
Arthritis
- BPC-157 — A 2014 rat study found intra-articular BPC-157 counteracted knee osteoarthritis and cartilage destruction; a small human pilot study reported reduced knee pain from injection, but there are no completed larger human trials.
- GHK-Cu — Copper inhibits the same MMP enzymes that break down cartilage, and a rat study found intra-articular GHK-Cu improved ACL-graft joint healing — though that benefit faded once treatment stopped, and there's no direct human osteoarthritis trial.
- GLOW — Contains BPC-157 and GHK-Cu, both separately studied for joint/cartilage-relevant effects in animal models (see individual entries).
- IGF-1 LR3 — Native IGF-1 is documented to protect cartilage and support chondrocyte function in osteoarthritis research — the evidence is for native IGF-1, not this longer-acting LR3 analog specifically, and IGF-1 LR3's own hypoglycemia risk (see caution below) is a real tradeoff to weigh against any joint benefit.
- KLOW — Contains BPC-157, KPV, and GHK-Cu — all three separately studied for joint/cartilage-relevant effects in animal models (see individual entries).
- KPV — As the active fragment of alpha-MSH, KPV shares its parent hormone's documented anti-inflammatory effects in rheumatoid arthritis animal models, largely by blocking NF-κB inflammatory signaling.
- Thymosin Alpha-1 — Studied as an immune-modulator (not simply an immune booster) in rheumatoid arthritis and other autoimmune diseases; evidence is preliminary and mostly observational rather than treatment trials.
Cancer Risk & Prevention
- FOXO4-DRI — One mouse study shows it may reduce chemotherapy-related toxicity — a side-effect finding, not evidence it prevents or treats cancer.
- GHK-Cu — A 2018 review proposes anti-cancer mechanisms (DNA repair, anti-inflammatory, antioxidant effects) — mechanistic, not a direct human prevention trial.
- MOTS-c — Studied for its exercise response specifically in breast cancer survivors — not tested as a cancer treatment or preventive itself.
- Tirzepatide — Carries an FDA boxed warning for possible thyroid tumors, seen in rodent studies — a risk flag, not a preventive benefit.
Cognitive & Mood
- Ara-290 — Studied clinically for nerve pain, linked to cognitive aspects.
- Oxytocin Acetate — Studied off-label for anxiety and social bonding effects.
- Pinealon — Targets cognitive function and memory support in animal studies.
- Selank — Anti-anxiety effects comparable to benzos without sedation in Russian studies.
- Semax — Improves attention and memory via BDNF/NGF in small human studies.
- VIP — Affects circadian rhythm, influencing mood and cognitive processes.
Diabetes
- Cagrilintide — Studied (with semaglutide, as CagriSema) for type 2 diabetes in phase 2 trials.
- MOTS-c — Animal studies show improved insulin sensitivity and glucose uptake in muscle.
- Retatrutide — Triple GLP-1/GIP/glucagon agonist also being studied for type 2 diabetes alongside its weight-loss trials.
- Semaglutide — FDA-approved (as Ozempic) for type 2 diabetes, with large trials showing sustained blood sugar control.
- Tirzepatide — FDA-approved (as Mounjaro) for type 2 diabetes, with the SURPASS trials showing strong glucose control.
Energy & Vitality
- CJC-1295 (No DAC) — GH-axis stimulation is commonly reported anecdotally to boost energy, though not established in trials.
- CJC-1295 (With DAC) — GH-axis stimulation is commonly reported anecdotally to boost energy, though not established in trials.
- GHRP-2 — GH-axis stimulation is commonly reported anecdotally to boost energy, though not established in trials.
- GHRP-6 — GH-axis stimulation is commonly reported anecdotally to boost energy, though not established in trials.
- Ipamorelin — GH-axis stimulation is commonly reported anecdotally to boost energy, though not established in trials.
- MOTS-c — Activates AMPK, a key cellular energy-sensing pathway; mimics some metabolic effects of exercise.
- NAD+ — Central coenzyme in cellular energy metabolism; popular for energy claims, though injectable-use trial evidence is limited.
- Sermorelin Acetate — GH-axis stimulation is commonly reported anecdotally to boost energy, though not established in trials.
- SS-31 — Targets mitochondria and stabilizes cardiolipin — FDA-approved for a rare mitochondrial energy-production disorder.
- Tesamorelin — GH-axis stimulation is commonly reported anecdotally to boost energy, though not established in trials.
Growth Hormone & Muscle
- CJC-1295 (No DAC) — Stimulates pituitary GH release, raising IGF-1 levels for muscle and fat effects.
- CJC-1295 (With DAC) — DAC-extended half-life provides sustained GH elevation vs. daily dosing.
- GHRP-2 — GHS stimulating GH release with appetite effects, raises cortisol more than selective secretagogues.
- GHRP-6 — Strong ghrelin-mimetic GHS for appetite and muscle mass, raises cortisol/prolactin.
- IGF-1 LR3 — Modified for extended muscle growth and tissue repair studies.
- Ipamorelin — Selective GH secretagogue stimulating pituitary GH release without significant cortisol rise.
- Sermorelin Acetate — GHRH analog with established mechanism for GH release, previously FDA-approved for diagnosis.
- Tesamorelin — Stimulates pituitary GH release, FDA-approved for HIV lipodystrophy fat reduction.
Healing & Recovery
- BPC-157 — Animal studies show accelerated healing of tendons, ligaments, and gut via collagen and blood vessel growth.
- GHK-Cu — Supports wound healing through collagen and tissue repair mechanisms.
- GLOW — Contains BPC-157 and TB-500, both studied for wound healing.
- KLOW — Contains BPC-157 and TB-500 with proven preclinical healing mechanisms.
- KPV — Research on gut-healing and skin inflammation in inflammatory conditions.
- TB-500 — Animal studies demonstrate faster wound healing through actin regulation and reduced inflammation.
Heart Health
- GHRP-6 — Shown to improve post-heart-attack ventricular remodeling in animal studies.
- Semaglutide — Large clinical trials show reduced cardiovascular risk in people with existing heart disease.
- SS-31 — Studied for mitochondrial dysfunction linked to heart failure and cardiac defects in Barth syndrome.
- TB-500 — Studied for cardiac tissue repair and reprogramming after heart injury in animal models.
Immune System
- Ara-290 — Investigated for inflammatory conditions and tissue protection.
- KLOW — Contains KPV, a component with established immune-modulating research.
- KPV — Studied for anti-inflammatory effects as an alpha-MSH fragment.
- LL-37 — Serves as a first line of defense in innate immunity.
- Selank — Derived from tuftsin, an immune-modulating protein, per its synthetic origin.
- Thymalin — Studied for immune modulation as a thymic peptide extract related to Thymosin Alpha-1.
- Thymosin Alpha-1 — Regulates T-cell activity, FDA-approved abroad for hepatitis and as vaccine adjuvant.
- VIP — Regulates immune function per natural hormone role in immune regulation.
Longevity & Mitochondrial
- Epithalon — Studied for telomerase activation in Russian longevity research.
- FOXO4-DRI — Senolytic targeting aged cells for anti-aging effects in mice.
- MOTS-c — Mitochondrial-encoded peptide activating AMPK, regulating nuclear gene expression.
- NAD+ — Essential coenzyme for energy metabolism and DNA repair.
- Pinealon — Part of Russian research tradition for neuroprotection.
- SS-31 — Targets mitochondria, stabilizes cardiolipin, FDA-approved for Barth syndrome.
Reduce Inflammation
- Ara-290 — Studied clinically for inflammatory conditions alongside diabetic neuropathy.
- KLOW — Contains KPV, an alpha-MSH-derived tripeptide specifically studied for anti-inflammatory effects.
- KPV — Specifically studied for anti-inflammatory effects in inflammatory bowel and skin conditions.
- Semax — Proposed to reduce inflammation after brain injury via BDNF/NGF pathways.
- TB-500 — Animal and cell studies show reduced inflammation alongside its wound-healing effects.
Respiratory
- VIP — Studied for pulmonary hypertension and inflammatory lung conditions like sarcoidosis.
Sexual Health & Hormonal
- HCG — Mimics LH to maintain testosterone production during TRT, FDA-approved for hormonal conditions.
- Kisspeptin-10 — Stimulates GnRH release driving reproductive hormone cascade.
- Melanotan II — Studied for libido effects, basis of Vyleesi approval.
- Oxytocin Acetate — Naturally involved in reproductive processes like childbirth.
- PT-141 — FDA-approved (Vyleesi) for hypoactive sexual desire via brain melanocortin receptors.
Sleep
- DSIP — Studied for regulating slow-wave (deep) sleep architecture.
- Epithalon — Experimental research included sleep architecture studies as part of longevity protocols.
Weight Loss & Metabolic
- AOD9604 — Designed to target fat metabolism without HGH effects, studied for fat loss.
- Cagrilintide — Reduces appetite as an amylin analog in obesity clinical trials.
- Mazdutide — Dual GLP-1/glucagon agonist developed for weight loss and metabolic health.
- MOTS-c — Activates AMPK, improving insulin sensitivity and glucose uptake in muscle (animal studies).
- Retatrutide — Phase 3 trials show largest average weight loss (24-29%) among GLP-1-class drugs.
- Semaglutide — FDA-approved GLP-1 agonist with clinical trials demonstrating significant weight loss and metabolic control.
- Survodutide — Dual agonist showing significant weight loss in late-stage trials.
- Tesamorelin — FDA-approved to reduce visceral abdominal fat in HIV-associated lipodystrophy.
- Tirzepatide — Dual GLP-1/GIP agonist showing greater average weight loss than GLP-1-only drugs in trials.
Other injectables
Prescription injectables that aren't peptides. They come premixed, so there's nothing to reconstitute.
- Testosterone Cypionate — Replaces testosterone itself, the main male sex hormone, in men with clinically low levels.
- Testosterone Enanthate — Replaces testosterone itself, the main male sex hormone, in men with clinically low levels.
This page in other languages: English · Español · Português · Français · Deutsch · Italiano · Nederlands · العربية · 中文 · 日本語 · Filipino · 한국어 · ไทย · हिन्दी · Bahasa Melayu · Русский
Dosify Me
